AI Blood Test for Alzheimer's Launched in India; Global Finger-Prick Trial Underway

• An AI-driven blood test for Alzheimer's detection has been introduced in India, aiming for earlier diagnosis and improved patient outcomes.
• This innovative test uses advanced algorithms to analyze blood samples and identify biomarkers associated with Alzheimer's disease, potentially detecting it years before symptoms appear.
• A separate international trial, led by LifeArc and Global Alzheimer's Platform Foundation, is testing a finger-prick blood test on 1,000 volunteers in the UK, US, and Canada.
• Current diagnostic methods like PET scans and lumbar punctures are expensive and invasive, with only 2 in 100 patients receiving them; the new tests offer a less invasive alternative.
• Dementia cases are projected to reach 139 million by 2050, with a significant shift towards developing nations like China, India, and South Asia.

Why It Matters: New AI blood tests offer hope for early, less invasive Alzheimer's diagnosis, crucial for future treatments.